Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1
小胶质细胞半乳糖凝集素3通过与Jag1竞争性结合抑制Notch信号通路,从而增强内皮细胞代谢并促进病理性血管生成。
阅读:4
作者:Zi-Yi Zhou # ,Tian-Fang Chang # ,Zhi-Bin Lin # ,Yu-Tong Jing ,Li-Shi Wen ,Ya-Li Niu ,Qian Bai ,Chang-Mei Guo ,Jia-Xing Sun ,Yu-Sheng Wang ,Guo-Rui Dou
| 期刊: | Cell Death & Disease | 影响因子: | 8.100 |
| 时间: | 2023 | 起止号: | 2023 Jun 28;14(6):380. |
| doi: | 10.1038/s41419-023-05897-8 | 方法学: | FCM、IF、IHC-P、WB |
| 靶点: | JAG1 | 研究方向: | 代谢、信号转导 |
| 细胞类型: | 胶质细胞 | 信号通路: | Notch |
Abstract
Microglia were considered as immune cells in inflammation until their angiogenic role was widely understood. Although the pro-inflammatory role of microglia in retinal angiogenesis has been explored, little is known about its role in pro-angiogenesis and the microglia-endothelia interaction. Here, we report that galectin-3 (Gal3) released by activated microglia functions as a communicator between microglia and endothelia and competitively binds to Jag1, thus inhibiting the Notch signaling pathway and enhancing endothelial angiogenic metabolism to promote angiogenesis. These results suggest that Gal3 may be a novel and effective target in the treatment of retinal angiogenesis.
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。